BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 34370157)

  • 1. Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation.
    Yang S; Wu L; Liao H; Lu X; Zhang X; Kuang X; Yang L
    Neurogenetics; 2021 Oct; 22(4):323-332. PubMed ID: 34370157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis and literature review of a Poirier-Bienvenu neurodevelopmental syndrome family line caused by a de novo frameshift variant in CSNK2B.
    Li D; Zhou B; Tian X; Chen X; Wang Y; Hao S; Zhang C; Hui L
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2327. PubMed ID: 38037515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poirier-Bienvenu neurodevelopmental syndrome: A report of a patient with a pathogenic variant in CSNK2B with abnormal linear growth.
    Selvam P; Jain A; Cheema A; Atwal H; Forghani I; Atwal PS
    Am J Med Genet A; 2021 Feb; 185(2):539-543. PubMed ID: 33166063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of de novo CSNK2A1 and CSNK2B variants in cases of global developmental delay with seizures.
    Nakashima M; Tohyama J; Nakagawa E; Watanabe Y; Siew CG; Kwong CS; Yamoto K; Hiraide T; Fukuda T; Kaname T; Nakabayashi K; Hata K; Ogata T; Saitsu H; Matsumoto N
    J Hum Genet; 2019 Apr; 64(4):313-322. PubMed ID: 30655572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing Interruption by Intron Variants in
    Zhang W; Ye F; Chen S; Peng J; Pang N; Yin F
    Front Neurosci; 2022; 16():892768. PubMed ID: 35774559
    [No Abstract]   [Full Text] [Related]  

  • 6. CSNK2B splice site mutations in patients cause intellectual disability with or without myoclonic epilepsy.
    Poirier K; Hubert L; Viot G; Rio M; Billuart P; Besmond C; Bienvenu T
    Hum Mutat; 2017 Aug; 38(8):932-941. PubMed ID: 28585349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding Phenotype of Poirier-Bienvenu Syndrome: New Evidence from an Italian Multicentrical Cohort of Patients.
    Orsini A; Santangelo A; Bravin F; Bonuccelli A; Peroni D; Battini R; Foiadelli T; Bertini V; Valetto A; Iacomino M; Nigro V; Torella AL; Scala M; Capra V; Vari MS; Fetta A; Di Pisa V; Montanari F; Epifanio R; Bonanni P; Giorda R; Operto F; Pastorino G; Sarigecili E; Sardaroglu E; Okuyaz C; Bozdogan S; Musante L; Faletra F; Zanus C; Ferretti A; Vigevano F; Striano P; Cordelli DM
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: Two cases of Poirier-Bienvenu neurodevelopmental syndrome and review of literature.
    Chen X; Han Y; Li X; Huang S; Yuan H; Qin Y
    Front Pediatr; 2023; 11():967701. PubMed ID: 37020656
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Yang Q; Zhang Q; Yi S; Qin Z; Shen F; Ou S; Luo J; He S
    Front Neurol; 2022; 13():811092. PubMed ID: 35370893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refining of the electroclinical phenotype in familial and sporadic cases of CSNK2B-related Neurodevelopmental Syndrome.
    Trivisano M; Dominicis A; Stregapede F; Quintavalle C; Micalizzi A; Cappelletti S; Dentici ML; Sinibaldi L; Calabrese C; Terracciano A; Vigevano F; Novelli A; Specchio N
    Epilepsy Behav; 2023 Oct; 147():109436. PubMed ID: 37717460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [De novo variant of CSNK2B causes Poirier-Bienvenu neurodevelopmental syndrome: two case report].
    Zhang J; Li Y; Luo H; Shen Y; Yuan M; Yang Z; Gan J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 May; 39(5):484-487. PubMed ID: 35598262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploinsufficiency as a Foreground Pathomechanism of Poirer-Bienvenu Syndrome and Novel Insights Underlying the Phenotypic Continuum of
    Di Stazio M; Zanus C; Faletra F; Pesaresi A; Ziccardi I; Morgan A; Girotto G; Costa P; Carrozzi M; d'Adamo AP; Musante L
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833176
    [No Abstract]   [Full Text] [Related]  

  • 13. Two different presentations of de novo variants of CSNK2B: two case reports.
    Wilke MVMB; Oliveira BM; Pereira A; Doriqui MJR; Kok F; Souza CFM
    J Med Case Rep; 2022 Jan; 16(1):4. PubMed ID: 34983633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline de novo variants in CSNK2B in Chinese patients with epilepsy.
    Li J; Gao K; Cai S; Liu Y; Wang Y; Huang S; Zha J; Hu W; Yu S; Yang Z; Xie H; Yan H; Wang J; Wu Y; Jiang Y
    Sci Rep; 2019 Nov; 9(1):17909. PubMed ID: 31784560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental and epilepsy spectrum of Poirier-Bienvenu neurodevelopmental syndrome: Description of a new case study and review of the available literature.
    Bonanni P; Baggio M; Duma GM; Negrin S; Danieli A; Giorda R
    Seizure; 2021 Dec; 93():133-139. PubMed ID: 34740143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder.
    Hiatt SM; Thompson ML; Prokop JW; Lawlor JMJ; Gray DE; Bebin EM; Rinne T; Kempers M; Pfundt R; van Bon BW; Mignot C; Nava C; Depienne C; Kalsner L; Rauch A; Joset P; Bachmann-Gagescu R; Wentzensen IM; McWalter K; Cooper GM
    Am J Hum Genet; 2019 Apr; 104(4):701-708. PubMed ID: 30879638
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Asif M; Kaygusuz E; Shinawi M; Nickelsen A; Hsieh TC; Wagle P; Budde BS; Hochscherf J; Abdullah U; Höning S; Nienberg C; Lindenblatt D; Noegel AA; Altmüller J; Thiele H; Motameny S; Fleischer N; Segal I; Pais L; Tinschert S; Samra NN; Savatt JM; Rudy NL; De Luca C; ; Paola Fortugno ; White SM; Krawitz P; Hurst ACE; Niefind K; Jose J; Brancati F; Nürnberg P; Hussain MS
    HGG Adv; 2022 Jul; 3(3):100111. PubMed ID: 35571680
    [No Abstract]   [Full Text] [Related]  

  • 18. CSNK2B: A broad spectrum of neurodevelopmental disability and epilepsy severity.
    Ernst ME; Baugh EH; Thomas A; Bier L; Lippa N; Stong N; Mulhern MS; Kushary S; Akman CI; Heinzen EL; Yeh R; Bi W; Hanchard NA; Burrage LC; Leduc MS; Chong JSC; Bend R; Lyons MJ; Lee JA; Suwannarat P; Brilstra E; Simon M; Koopmans M; van Binsbergen E; Groepper D; Fleischer J; Nava C; Keren B; Mignot C; Mathieu S; Mancini GMS; Madan-Khetarpal S; Infante EM; Bluvstein J; Seeley A; Bachman K; Klee EW; Schultz-Rogers LE; Hasadsri L; Barnett S; Ellingson MS; Ferber MJ; Narayanan V; Ramsey K; Rauch A; Joset P; Steindl K; Sheehan T; Poduri A; Vasquez A; Ruivenkamp C; White SM; Pais L; Monaghan KG; Goldstein DB; Sands TT; Aggarwal V
    Epilepsia; 2021 Jul; 62(7):e103-e109. PubMed ID: 34041744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo mutations in HNRNPU result in a neurodevelopmental syndrome.
    Yates TM; Vasudevan PC; Chandler KE; Donnelly DE; Stark Z; Sadedin S; Willoughby J; ; ; Balasubramanian M
    Am J Med Genet A; 2017 Nov; 173(11):3003-3012. PubMed ID: 28944577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy.
    Parenti I; Lehalle D; Nava C; Torti E; Leitão E; Person R; Mizuguchi T; Matsumoto N; Kato M; Nakamura K; de Man SA; Cope H; Shashi V; ; Friedman J; Joset P; Steindl K; Rauch A; Muffels I; van Hasselt PM; Petit F; Smol T; Le Guyader G; Bilan F; Sorlin A; Vitobello A; Philippe C; van de Laar IMBH; van Slegtenhorst MA; Campeau PM; Au PYB; Nakashima M; Saitsu H; Yamamoto T; Nomura Y; Louie RJ; Lyons MJ; Dobson A; Plomp AS; Motazacker MM; Kaiser FJ; Timberlake AT; Fuchs SA; Depienne C; Mignot C
    Hum Genet; 2021 Jul; 140(7):1109-1120. PubMed ID: 33944996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.